Ledger.Open graph →
SEC Form D · filed May 1, 2018

CORVIDIA THERAPEUTICS, INC

Offering
$60.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Marc De Garidel · WALTHAM, MAExec · DirectorRam Aiyar · WALTHAM, MAExecAaron Kantoff · NEW YORK, NYDirectorKarim Helmy · WALTHAM, MADirectorSylvie Gregoire · WALTHAM, MADirectorTyrell Rivers · WALTHAM, MADirectorGraziano Seghezzi · WALTHAM, MADirectorRam Aiyar · WALTHAM, MAExecAaron Kantoff · NEW YORK, NYDirectorKarim Helmy · WALTHAM, MADirectorMarc De Garidel · WALTHAM, MAExec · DirectorSylvie Gregoire · WALTHAM, MADirectorTyrell Rivers · WALTHAM, MADirectorGraziano Seghezzi · WALTHAM, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗